StockData
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc (IONS) stock

IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/301% below fair value
$28.01−1.05 (-3.61%)

Close on Nov 16, 2026Market cap $4.65BP/E –Yield –

Ionis Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Ionis Pharmaceuticals's total assets was $2.99B at Jun 30, 2026. For fiscal 2025 it was $3.52B, up 17.3% from the year before. Over ten years it grew 14.0% a year on average. The highest annual figure on record is $3.52B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.52B+17.3%
FY2024Dec 31, 2024$3.00B+0.5%
FY2023Dec 31, 2023$2.99B+18.0%
FY2022Dec 31, 2022$2.53B-3.0%
FY2021Dec 31, 2021$2.61B+9.3%
FY2020Dec 31, 2020$2.39B-26.1%
FY2019Dec 31, 2019$3.23B+21.2%
FY2018Dec 31, 2018$2.67B+101.7%
FY2017Dec 31, 2017$1.32B+45.0%
FY2016Dec 31, 2016$912.47M-3.7%
FY2015Dec 31, 2015$947.90M-0.8%
FY2014Dec 31, 2014$955.81M+12.8%
FY2013Dec 31, 2013$847.16M+55.2%
FY2012Dec 31, 2012$545.69M+12.5%
FY2011Dec 31, 2011$484.89M-11.9%
FY2010Dec 31, 2010$550.48M-16.2%
FY2009Dec 31, 2009$657.18M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.99B+0.3%
Q1 FY2026Mar 31, 2026$3.45B+22.6%
Q4 FY2025Dec 31, 2025$3.52B+17.3%
Q3 FY2025Sep 30, 2025$3.03B-1.6%
Q2 FY2025Jun 30, 2025$2.99B+10.9%
Q1 FY2025Mar 31, 2025$2.81B+1.8%
Q4 FY2024Dec 31, 2024$3.00B+0.5%
Q3 FY2024Sep 30, 2024$3.08B+5.0%
Q2 FY2024Jun 30, 2024$2.69B-9.4%
Q1 FY2024Mar 31, 2024$2.76B-4.2%
Q4 FY2023Dec 31, 2023$2.99B+18.0%
Q3 FY2023Sep 30, 2023$2.93B+21.1%
Q2 FY2023Jun 30, 2023$2.97B+21.0%
Q1 FY2023Mar 31, 2023$2.89B+14.5%
Q4 FY2022Dec 31, 2022$2.53B-3.0%
Q3 FY2022Sep 30, 2022$2.42B+0.3%
Q2 FY2022Jun 30, 2022$2.46B-1.6%
Q1 FY2022Mar 31, 2022$2.52B+12.0%
Q4 FY2021Dec 31, 2021$2.61B+9.3%
Q3 FY2021Sep 30, 2021$2.41B-22.0%
Q2 FY2021Jun 30, 2021$2.50B-18.9%
Q1 FY2021Mar 31, 2021$2.25B-27.3%
Q4 FY2020Dec 31, 2020$2.39B-26.1%
Q3 FY2020Sep 30, 2020$3.10B+6.9%
Q2 FY2020Jun 30, 2020$3.08B+7.0%
Q1 FY2020Mar 31, 2020$3.09B+9.0%
Q4 FY2019Dec 31, 2019$3.23B+21.2%
Q3 FY2019Sep 30, 2019$2.89B+28.8%
Q2 FY2019Jun 30, 2019$2.88B+28.1%
Q1 FY2019Mar 31, 2019$2.84B+118.2%
Q4 FY2018Dec 31, 2018$2.67B+101.7%
Q3 FY2018Sep 30, 2018$2.25B+79.5%
Q2 FY2018Jun 30, 2018$2.25B+106.0%
Q1 FY2018Mar 31, 2018$1.30B+19.9%
Q4 FY2017Dec 31, 2017$1.32B+45.0%
Q3 FY2017Sep 30, 2017$1.25B+48.5%
Q2 FY2017Jun 30, 2017$1.09B–
Q1 FY2017Mar 31, 2017$1.08B–
Q4 FY2016Dec 31, 2016$912.47M–
Q3 FY2016Sep 30, 2016$843.59M–

More Ionis Pharmaceuticals figures

See a number that looks wrong?